KUZU, I. Et Al. 2020. Molecular Alterations Obtained by High-Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targeted Therapies. 2nd AMP Europe Congress on Clinical Genomics - Beyond the Somatic Mutation .

KUZU, I., CENGİZ SEVAL, G., YÜKSEL, M., KAYGUSUZ, G., DALVA, K., ÖZCAN, M., ... BEKSAÇ, M.(2020). Molecular Alterations Obtained by High-Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targeted Therapies . 2nd AMP Europe Congress on Clinical Genomics - Beyond the Somatic Mutation

KUZU, IŞINSU Et Al. "Molecular Alterations Obtained by High-Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targeted Therapies," 2nd AMP Europe Congress on Clinical Genomics - Beyond the Somatic Mutation, 2020

KUZU, IŞINSU Et Al. "Molecular Alterations Obtained by High-Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targeted Therapies." 2nd AMP Europe Congress on Clinical Genomics - Beyond the Somatic Mutation , 2020

KUZU, I. Et Al. (2020) . "Molecular Alterations Obtained by High-Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targeted Therapies." 2nd AMP Europe Congress on Clinical Genomics - Beyond the Somatic Mutation .

@conferencepaper{conferencepaper, author={IŞINSU KUZU Et Al. }, title={Molecular Alterations Obtained by High-Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targeted Therapies}, congress name={2nd AMP Europe Congress on Clinical Genomics - Beyond the Somatic Mutation}, city={}, country={}, year={2020}}